Intranasal absorption of the platelet glycoprotein IIb/IIIa receptor antagonist, DMP 755, and the effect of anesthesia on nasal bioavailability

Journal of Pharmaceutical Sciences

Volumn 86, Issue 12, 1997, Pages 1358-1360

  Hussain, Munir A ^a   Aungst, Bruce J ^a   Kapil, Ram ^a   Mousa, Shaker A ^a  

^a DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; DMP 755; FIBRINOGEN RECEPTOR ANTAGONIST; PENTOBARBITAL; PRODRUG; PROPOFOL; UNCLASSIFIED DRUG;

ANESTHESIA; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; DOG; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG HALF LIFE; FEMALE; INTRANASAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; SEDATION;

EID: 0031446182     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js970208r     Document Type: Article

References (16)

1. Pytela, R.; Pierschbacher, M. D.; Ginsberg, M. H.; Plow, E. F.; Ruoslahti, E. Science 1986, 231, 1559-1562
2. D'Souza, S. E.; Ginsberg, M. H.; Burke, T. A.; Plow, E. F. J. Biol. Chem. 1990, 265, 3440-3446
3. Hirsh, P. D.; Hillis, L. D.; Campbell; W. B.; Firth, B. G.; Willerson, J. T. N. Engl. J. Med. 1981, 304, 685-691
4. Rubenstein, M. D.; Wall, R. T.; Bairn, D. S.; Harrison, D. C. Am. Heart J. 1981, 102, 363-367.
5. Smitherman, T. C.; Milam, M.; Woo, J.; Willerson, J. T.; Frenkel, E. P. Am. J. Cardiol. 1981, 48, 395-402.
6. Fitzgerald, D. J.; Roy, L.; Catella, F.; Fitzgerald, G. A. N. Engl. J. Med. 1986, 315, 983-989.
7. Fuster V.; Steele, P. M.; Chesebro, J. H. J. Am. Colloid Cardiol. 1985, 5, 175B-184B.
8. Ruggeri, Z. M.; Houghton, R. A.; Russel, S. R.; Zimmerman, T. S. Proc. Natl. Acad. Sci. U.S.A. 1986, 83, 5708-5712.
9. Nicholson, N. S.; Panzer-Knodle, S. G.; Salyers A. K.; Taite, B. B.; King, L. W.; Miyano, M.; Gorczynski, R. J.; Williams, M. H.; Zupec, M. E.; Tjoenge F. S. Thromb Res. 1991, 62, 567-578.
10. Nichols, A. J.; Ruffolo, R. R.; Huffman, W. F.; Poste, G.; Samanen, J. Trends Pharmacol. Sci. 1992, 13, 413-417.
11. Theroux P.; White, H.; David, D.; Van de Wert, F.; Nienaber, C. A.; Charbonnier, B.; Erhardt, L.; Gill, J.; Hillis, W. S.; Jennings, G.; Tam, L-B; Deschenes, N.; Fitzpatrick, V.; Sax, F. l., Circulation 1994, 90, I-231, 1242.
12. Austel, V.; Himmelsbach, F.; Muller, T. Drugs Future 1994, 19, 757-769.
13. Kapil, R.; Padovani, P. K.; Garner, D. M.; Chien, B. M.; Quon, C. Y.; Lam, G. N. Pharm. Res. 1996, 13, S-497.
14. Mousa, S. A.; Forsythe, M.; Lorelli, W.; Bozarth, C.; Xue, C-B; Wityak J.; Sielecki, T. M.; Olson, R. E.; DeGrado, W.; Kapil, R.; Hussain, M.; Wexler, R.; Thoolen, M. J.; Reilly, T. M. Coron. Art. Dis. 1996, 7, 767-774.
15. Schipper, N. G. M.; Verhoef, F. C.; Merkus, F. W. H. M. Pharm. Res. 1991, 8, 807-814.
16. Gizurarson, S. Acta Pharm. Nord. 1990, 2, 105-122.